Previous Video Next Video

video thumbnail

Mixing Vaccine Types - UK Study

Duration: 12:18

Write A New Comment

0 Comments

Mixing Vaccine Types - Oxford University Study

Oxford University is conducting vaccine type mixing for prime dose and the booster dose. In a preliminary data set they have printed the side-effects of mixing the vaccine types. Let’s review the initial reactogenicity data published in Lancet.

Some news: CDC says mask not required for fully vaccinated in certain situations. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html

British airway is trialing highly intelligent 25 seconds saliva based coronavirus test. https://news.sky.com/story/covid-19-ultra-rapid-25-second-coronavirus-test-hailed-as-a-game-changer-in-british-airways-trial-12305272

Now to today’s topic
Initial reactogenicity data printed in lancet
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01115-6/fulltext

Link with the study protocols
https://comcovstudy.org.uk/study-protocol
Study protocol V5.0
https://comcovstudy.org.uk/files/com-covprotocolv5026-apr-2021finalpdf
Study protocol V2.1
https://comcovstudy.org.uk/files/com-cov2protocolv2123-apr-2021cleanpdf

A study conducted by Oxford University in the UK found that mixing Pfizer-BioNTech and AstraZeneca COVID vaccines had some unexpected results. Let's review the study and its results.

We will discuss:

Study design
Vaccine types included in the study.
Dosage gap and mixing strategy.
The difference in side effects of heterogenous vs. homogenous vaccine doses.
Comparison of the antibody titers with heteregenous vs., homogenous vaccine schedules.

Presented by Dr. Mobeen Syed

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Pharmacology

Videos in Course
Favourite Videos

Clinical Application of Cardiac Drugs/Cardiac Pharmacology

27:29

Ahmed Zaafran, MD

Clinical Applications of Anti-Dysrhythmia Drugs

20:05

Ahmed Zaafran, MD

Clinical Applications of Anti-Inflammatory/Anti-Histamine Drugs

36:23

Ahmed Zaafran, MD

Clinical Applications of Antihypertensive Drugs (Part 1)

19:02

Ahmed Zaafran, MD

Diagnosis and Management of Hypertension

48:55

Ahmed Zaafran, MD

Clinical Application of Cardiac Drugs/Cardiac Pharmacology

27:29

Ahmed Zaafran, MD

Management of Atrial Fibrillation

34:02

Dr. Mobeen Syed

0.50 CME

Cardiac Drugs: Inotropes, Vasopressors, and Vasodilators Part 1

33:33

Luis A Verduzco M.D.

0.75 CME

Cardiac Drugs: Inotropes, Vasopressors, and Vasodilators Part 2

48:59

Luis A Verduzco M.D.

0.50 CME

Low Dose Naltrexone (LDN) - Mechanism of Action

34:43

Dr. Mobeen Syed

0.50 CME

Future Antivirals Using Bacterial Immune Sensors

26:02

Dr. Mobeen Syed

(Webinar) Managing Type II Diabetes Mellitus (Part 9)

27:26

Dr. Mobeen Syed

(Webinar) Managing Type II Diabetes Mellitus (Part 10)

29:05

Dr. Mobeen Syed

Metformin and General Considerations to Mange Type II Diabetes Mellitus (Managing Type II Diabetes Mellitus - Part 8. Webinar)

47:37

Dr. Mobeen Syed

Drug Classes to Manage Type II Diabetes Mellitus (Managing Type II Diabetes Mellitus - Part 7. Webinar)

40:48

Dr. Mobeen Syed

(Webinar) Dyslipidemia Management-ACC/AHA guideline Overview

44:42

Dr. Mobeen Syed

1.50 CME

Insulin Synthesis, Secretion, and Regulation

1:34:58

Dr. Mobeen Syed

1.50 CME

Master Insulin Therapy (full video)

1:22:37

Dr. Mobeen Syed

How Does Ozempic Work?

25:07

Clinical Application of Cholinergic Drugs/Cholinergic System

51:32

Ahmed Zaafran, MD

Clinical Applications of Respiratory Drugs (Part 1)/ Asthma

26:05

Ahmed Zaafran, MD

Clinical Application of Respiratory Drugs (Part2) / Asthma

22:41

Ahmed Zaafran, MD

Clinical Applications of Anti-Histamine Medications (Part 1)/Common Cold

19:06

Ahmed Zaafran, MD

Clinical Applications of Anti-Histamine Drugs (Part 2)/Common Cold

19:41

Ahmed Zaafran, MD

1.25 CME

(Webinar) Peptic Ulcer Disease and the Role of PPIs

1:13:38

Sameer Islam, MD

Overview of the Pediatric Vaccination Schedules

1:56:21

Tammy Wang, MD

0.21 CME

Penicillin: Mechanism of Action

12:15

Dr. Mobeen Syed

0.75 CME

Sedation and Analgesia

51:09

Luis A Verduzco M.D.

0.12 CME

Nitric Oxide

07:12

Dr. Mobeen Syed

How Dostarlimab Therapy Healed Colorectal Cancer

31:04

Dr. Mobeen Syed

Potential New Killer Cells for Cancer Immunotherapy

30:23

Dr. Mobeen Syed

Story of Ivermectin Nobel Prize

16:50

Dr. Mobeen Syed

1.00 CME

Opioid Receptor Activation and Tolerance (Pain Part 5)

53:40

Dr. Mobeen Syed

Merck’s Molnupiravir (EIDD-281) Effective Against SARS-COV-2

29:11

Dr. Mobeen Syed

Maraviroc Mechanism of Action (MOA)

32:44

Dr. Mobeen Syed

Low Histamine Diets

19:50

Dr. Mobeen Syed

IVIg A High Level Overview

23:23

Dr. Mobeen Syed

Mixing Vaccine Types - UK Study

12:18

Dr. Mobeen Syed

Administration of Second Dose Of Moderna Vaccine After An Immediate Hypersensitivity Reaction to The First Dose

10:46

Dr. Mobeen Syed

Nasal Spray for Virus/SARS-COV-2 Reduction

21:28

Dr. Mobeen Syed

How is AstraZeneca Vaccine Made

07:06

Dr. Mobeen Syed

Covaxin, A Vaccine from India

30:56

Dr. Mobeen Syed

Sputnik Vaccine is 91.6% Effective

19:30

Dr. Mobeen Syed

Interferon Beta - A New Study

18:05

Dr. Mobeen Syed

Vitamin D, Dust and Covid-19

15:42

Dr. Mobeen Syed

Regeneron Antibody Cocktail

08:53

Dr. Mobeen Syed

0.50 CME

Macrolide - Azithromycin

24:12

Dr. Mobeen Syed

Famotidine (H2 Receptor Antagonist)

28:20

Dr. Mobeen Syed

Norepinephrine

32:19

Dr. Mobeen Syed

Favipiravir

26:05

Dr. Mobeen Syed

Iodine and Its Medical Uses

26:07

Dr. Mobeen Syed

Dexamethasone

28:41

Dr. Mobeen Syed

0.50 CME

COVID-19 and Aspirin

28:13

Dr. Mobeen Syed

Magnesium

35:04

Dr. Mobeen Syed

Melatonin

30:38

Dr. Mobeen Syed

Tocilizumab An IL6 Receptor Blocker

34:49

Dr. Mobeen Syed

Camostat Mesylate

25:14

Dr. Mobeen Syed

0.50 CME

NAC N-Acetylcysteine

27:41

Dr. Mobeen Syed

Convalescent Plasma For COVID-19 Patients

50:28

Dr. Mobeen Syed

Androgens Physiological and Pharmacological Aspects (Lecture 1)

29:33

Dr. Mobeen Syed

Androgens - What Controls Androgen Release (Lecture 2)

28:44

Dr. Mobeen Syed

Antiandrogens - A High-Level Overview (Lecture 3)

35:26

Dr. Mobeen Syed

Study - Antiandrogens Reduce COVID Hospitalization, Deaths, And Disease Progress

19:22

Dr. Mobeen Syed

Study - Antiandrogens (Dutasteride) For Mild COVID Cases

20:13

Dr. Mobeen Syed

Related Videos

All information contained in and produced by DrBeen corp is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease.

THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.

Click here for notice and disclaimer.

Copyright © 2015-2024 all rights reserved by DrBeen Corp